ISB News

ISB Innovations: Ultrasound-Based Tumor Biopsies

John Chevillet is a postdoc in the Hood Lab at Institute for Systems Biology in Seattle.
Name:

John Chevillet, PhD

Lab:

Hood

Research:

I am trying to develop an ultrasound-based method to take a sample from a tumor, thus replacing needle biopsies. An ultrasound-based method would minimize complications, better diagnose cancers, and direct the use of targeted therapies for personalized medicine.

Wish List:

If I had $10,000, I could analyze the blood specimens we currently have for cancer dna to demonstrate what this method can tell us about the mutations driving a tumor. If I had $100,000, I could analyze a wide spectrum of molecules (DNA, RNA and protein) and start to define a biomarker signature panel that could be used as a foundation for a test more accurate than what we have now. If I had $1 million, I could partner with physicians and patients to test this method.

How you can help:

Watch this short video and click the button at the end of the video. Or donate now.

If you have questions about this project or would like to speak directly with our researchers, contact us.

 

Related Articles

  • ISB's Dr. Sui Huang Earns Funding to Tackle Cancer's Biggest Questions

    ISB’s Professor Sui Huang, MD, PhD, has been announced by Cancer Research UK as a member of a global research team funded through its Grand Challenge competition — an international funding initiative that aims to answer some of the biggest questions facing cancer research.

    Read More
  • ISB President Dr. Jim Heath

    ISB President Dr. Jim Heath Awarded $750,000 from Andy Hill Cancer Research Endowment

    The Andy Hill Cancer Research Endowment (CARE) announced $750,000 in grant funding for Dr. Jim Heath’s work on proactive cancer immunotherapies for initial and recurrent disease. This is the first stage of a planned longer program led by Jim and ISB, and involving Swedish Cancer Institute, Earl A. Chiles Research Institute in Portland, and UW Medicine.

    Read More
  • Dr. Sui Huang

    New Principle for Eradicating Cancer: Leave No Dead Cells Behind

    Dead cells, or cell debris, generated by treatments intended to eradicate tumor cells actually act as strong stimulators of tumor progression. The findings of ISB cancer biologist Sui Huang, his former mentee and longtime collaborator Dipak Panigrahy at Beth Isreal Deaconess Medical Center in Boston, and colleagues at Harvard Medical School were published in The Journal of Experimental Medicine.

    Read More
Show More Articles